<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00741728</url>
  </required_header>
  <id_info>
    <org_study_id>C07-39</org_study_id>
    <secondary_id>2007-A01386-47</secondary_id>
    <nct_id>NCT00741728</nct_id>
  </id_info>
  <brief_title>Heart Rate, Baroreflex Sensitivity and Cardiovascular Morbidity and Mortality in the Population</brief_title>
  <acronym>PPSIII</acronym>
  <official_title>Heart Rate, Baroreflex Sensitivity and Cardiovascular Morbidity and Mortality in the Population. The Paris Prospective Study III</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present PPS3 study is (1) to assess the determinants of the regulation of
      heart rate and blood pressure variations and carotid properties (under different physiologic
      stimulations) and (2) to evaluate the respective contribution of heart rate, blood pressure
      variations and carotid properties to cardiovascular morbidity and mortality including sudden
      death during 10 years at least in healthy considered subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Overall, 10 000 men and women will be recruited during two years for an extensive clinical
      examination including a 2h holter ECG, a carotid doppler echo tracking, a step test, as well
      as blood and DNA collections. Thereafter, the cardiovascular morbidity and mortality of the
      participants will be followed up for 10 years at least.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>cardiovascular disease</measure>
    <time_frame>after 10 years of follow up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>heart rate parameters and baroreflex sensitivity</measure>
    <time_frame>after 2 years of recruitment</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Community Based Study</condition>
  <condition>Cardiovascular Disease</condition>
  <condition>Sudden Death</condition>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>general population</arm_group_label>
    <description>Observational study of 10000 adult men and women from the general population who benefited from a free extensive health check up in Paris, France</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Spider flash EKG, echocardiography tracking, step test</intervention_name>
    <description>cardiac rhythm recorded during health check up, echocardiography tracking of the right common carotid, step test during 2 minutes</description>
    <arm_group_label>general population</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples and DNA taken from fresh blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult men and women affiliated to the public French Health Insurance System who benefited
        from a free general health check up paid by the French Health Insurance System
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  50-75 years, French speaking, given consent for genetic analysis,

          -  written consent for participating in the study

        Exclusion Criteria:

          -  &lt;50 years and &gt;75 years,

          -  no French speaking,

          -  current pregnancy,

          -  chronic severe disease,

          -  disagreement for genetic analysis,

          -  step test considered as non possible or non advisable by medical decision.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xavier Jouven, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>INSERM and APHP</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Philippe Empana, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut National de la Santé Et de la Recherche Médicale, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre Boutouyrie, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>INSERM and APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xavier Jouven, MD, PhD</last_name>
    <phone>1 56 09 36 87</phone>
    <phone_ext>33</phone_ext>
    <email>xavier.jouven@egp.aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean-Philippe Empana, MD, PhD</last_name>
    <phone>1 53 98 80 20</phone>
    <phone_ext>33</phone_ext>
    <email>jean-philippe.empana@inserm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Investigations Pré cliniques et Preventives de Paris</name>
      <address>
        <city>Paris</city>
        <zip>75016</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Philippe Empana, MD, PhD</last_name>
      <phone>33 1 53 98 80 20</phone>
      <phone_ext>33</phone_ext>
      <email>jean-philippe.empana@inserm.fr</email>
    </contact>
    <investigator>
      <last_name>Xavier Jouven, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.inserm.fr</url>
    <description>official website of the French National Institute for Health and Medical Research</description>
  </link>
  <reference>
    <citation>Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetière P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med. 2005 May 12;352(19):1951-8.</citation>
    <PMID>15888695</PMID>
  </reference>
  <reference>
    <citation>Jouven X, Zureik M, Desnos M, Courbon D, Ducimetière P. Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N Engl J Med. 2000 Sep 21;343(12):826-33.</citation>
    <PMID>10995861</PMID>
  </reference>
  <reference>
    <citation>Briet M, Bozec E, Laurent S, Fassot C, London GM, Jacquot C, Froissart M, Houillier P, Boutouyrie P. Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney Int. 2006 Jan;69(2):350-7.</citation>
    <PMID>16408126</PMID>
  </reference>
  <reference>
    <citation>Kornet L, Hoeks AP, Janssen BJ, Houben AJ, De Leeuw PW, Reneman RS. Neural activity of the cardiac baroreflex decreases with age in normotensive and hypertensive subjects. J Hypertens. 2005 Apr;23(4):815-23.</citation>
    <PMID>15775787</PMID>
  </reference>
  <reference>
    <citation>Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, Amouyel P, Bingham A, Montaye M, Ruidavets JB, Haas B, Evans A, Jouven X, Ducimetiere P; PRIME Study Group. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation. 2005 May 10;111(18):2299-305. Epub 2005 May 2.</citation>
    <PMID>15867179</PMID>
  </reference>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2008</study_first_submitted>
  <study_first_submitted_qc>August 25, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2008</study_first_posted>
  <last_update_submitted>December 8, 2011</last_update_submitted>
  <last_update_submitted_qc>December 8, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>epidemiology</keyword>
  <keyword>risk factors</keyword>
  <keyword>heart rate</keyword>
  <keyword>baroreflex sensitivity</keyword>
  <keyword>sudden death</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Death, Sudden</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

